Tayo Adekiya to Antineoplastic Agents
This is a "connection" page, showing publications Tayo Adekiya has written about Antineoplastic Agents.
Connection Strength
0.984
-
Adekiya TA, Owoseni O. Emerging frontiers in nanomedicine targeted therapy for prostate cancer. Cancer Treat Res Commun. 2023; 37:100778.
Score: 0.544
-
Adekiya TA, Hudson T, Bakare O, Ameyaw EE, Adebayo A, Olajubutu O, Adesina SK. PSMA-targeted combination brusatol and docetaxel nanotherapeutics for the treatment of prostate cancer. Biomed Pharmacother. 2024 Aug; 177:117125.
Score: 0.142
-
Ojo OA, Aruleba RT, Adekiya TA, Sibuyi NRS, Ojo AB, Ajiboye BO, Oyinloye BE, Adeola HA, Fadaka AO. Deciphering the interaction of puerarin with cancer macromolecules: An in silico investigation. J Biomol Struct Dyn. 2022 02; 40(2):848-859.
Score: 0.109
-
Oyinloye BE, Adekiya TA, Aruleba RT, Ojo OA, Ajiboye BO. Structure-Based Docking Studies of GLUT4 Towards Exploring Selected Phytochemicals from Solanum xanthocarpum as a Therapeutic Target for the Treatment of Cancer. Curr Drug Discov Technol. 2019; 16(4):406-416.
Score: 0.097
-
Aruleba RT, Adekiya TA, Oyinloye BE, Kappo AP. Structural Studies of Predicted Ligand Binding Sites and Molecular Docking Analysis of Slc2a4 as a Therapeutic Target for the Treatment of Cancer. Int J Mol Sci. 2018 Jan 28; 19(2).
Score: 0.091